Select a Sector or Industry
Revenue Growth Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Revenue Growth
|
Pro Rating
|
|---|---|---|---|---|
| 1 | DRRX | Durect Corporation | 378.7% | Go Pro |
| 2 | MAPP | MAP Pharmaceuticals | 84.23% | Go Pro |
| 3 | SCLN | SciClone Pharmaceuticals | 80.79% | Go Pro |
| 4 | ALXA | Alexza Pharmaceuticals | 49.64% | Go Pro |
| 5 | TARO | Taro Pharmaceutical Industries | 44.92% | Go Pro |
| 6 | PTX | Pernix Therapeutics | 43.46% | Go Pro |
| 7 | DVAX | Dynavax Technologies Corporation | 34.75% | Go Pro |
| 8 | CRME | Cardiome Pharma Corporation | 33.33% | Go Pro |
| 9 | CBST | Cubist Pharmaceuticals | 30.25% | Go Pro |
| 10 | UTHR | United Therapeutics Corporation | 25.66% | Go Pro |
| 11 | ENDP | Endo Health Solutions | 23.32% | Go Pro |
| 12 | RDY | Dr. Reddy's Laboratories | 23.11% | Go Pro |
| 13 | DUSA | DUSA Pharmaceuticals | 22.21% | Go Pro |
| 14 | SCMP | Sucampo Pharmaceuticals | 18.66% | Go Pro |
| 15 | LCI | Lannett Company | 18.52% | Go Pro |
| 16 | SOMX | Somaxon Pharmaceuticals | 18.04% | Go Pro |
| 17 | MDCO | The Medicines Company | 12.91% | Go Pro |
| 18 | ISIS | Isis Pharmaceuticals | 9.87% | Go Pro |
| 19 | NVO | Novo Nordisk | 9.69% | Go Pro |
| 20 | AGN | Allergan | 9.50% | Go Pro |
| 21 | ALTH | Allos Therapeutics | 4.33% | Go Pro |
| 22 | CPIX | Cumberland Pharmaceuticals | -3.85% | Go Pro |
| 23 | NGSX | NeurogesX | -6.21% | Go Pro |
| 24 | PCYC | Pharmacyclics | -6.41% | Go Pro |
| 25 | FRX | Forest Laboratories | -7.25% | Go Pro |
| 26 | ISTA | ISTA Pharmaceuticals | -7.37% | Go Pro |
| 27 | PTIE | Pain Therapeutics | -8.13% | Go Pro |
| 28 | SCR | Simcere Pharmaceutical Group | -8.82% | Go Pro |
| 29 | WCRX | Warner Chilcott | -9.51% | Go Pro |
| 30 | GENT | Gentium | -9.84% | Go Pro |
| 31 | RDEA | Ardea Biosciences | -16.61% | Go Pro |
| 32 | TPI | Tianyin Pharmaceutical | -28.01% | Go Pro |
| 33 | NBY | NovaBay Pharmaceuticals | -46.99% | Go Pro |
| 34 | OREX | Orexigen Therapeutics | -53.12% | Go Pro |
| 35 | POZN | Pozen | -71.11% | Go Pro |
| 36 | DEPO | Depomed | -79.74% | Go Pro |
| 37 | APRI | Nexmed | -86.21% | Go Pro |
